ECOR
electroCore, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$11.68
+2.64%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$11.35
From 52W high+0.00%
Volume97537.00
Market cap$105.31M
P/E (TTM)—
P/S (TTM)2.8x
Div yield—
Key dataSep 18, 2026
Open
$11.35
From 52W high
+0.00%
Volume
97537.00
Market cap
$105.31M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.4x
P/E (TTM)
—
RSI (14)
71.0
MomentumView details →
1D Return
+2.64%
YTD Return
+153.23%
SummaryUpdated Jun 1, 2026
electroCore, Inc. (NASDAQ:ECOR) is a commercial-stage medical device company founded in 2005 and headquartered in Rockaway, New Jersey. The company specializes in developing and commercializing non-invasive vagus nerve stimulation (nVNS) therapies through its flagship gammaCore technology platform. Since going public in 2018, electroCore has expanded beyond prescription medical devices into direct-to-consumer wellness products and military performance applications. In 2024, the company strategically acquired NeuroMetrix to broaden its bioelectronic health portfolio, positioning itself as a diversified player in the emerging field of bioelectronic medicine.
Similar companies
Latest newsMore news →
Mike Fox was appointed Co-Chief Executive Officer and member of the Board of Directors of electroCore, Inc., effective September 8, 2026.11d agoelectroCore, Inc. reported a second-quarter loss of $0.33 per share, beating the Zacks Consensus Estimate of a loss of $0.41 and improving from a loss of $0.35 per share a year ago.45d ago